Business
UBS, Minters help Arrotex in $205m McPherson’s bid – The Australian Financial Review
Rich Lister Ruffy Geminder has got a fight on his hands at ASX-listed beauty company and takeover target McPherson’s.
And while McPhersons board said Gallins offer undervalued the company, it said it would give Arrotex access to due diligence information and progress discussions, with a view to developing a transaction to put to shareholders.
Arrotex was formed in 2019, following the merger of Arrow Pharmaceuticals and Apotex Australia. The company supplies generic pharmaceuticals, over the counter products and vitamins to pharmacies around the country.
Meanwhile, McPhersons supplies health, wellness and beauty…
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
General11 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Noosa News17 hours agoSenior constable injured in crash between unmarked police car and stolen vehicle in Pimpama, Queensland
-
Business22 hours agoASX 200 mining shares rip as lithium makes a comeback